Paiva B, Burgos L, Gonzalez C, Ahdadi A, et al. Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy. Leukemia 2026 Oct 8. doi: 10.1038/s41375-026-03153.
PMID: 42850349